• Contact Us
  • Register
  • Sign In
PHACS PHACS
  • Home
  • About Us
    • Mission and Values
    • Leadership
    • Participating Organizations
    • Funding
    • Clinical Site Feature Profiles
    • PHACS Puerto Rico Hurricane Relief
    • Inspiration Hub
    • In Memoriam
    • Contact Us
  • Our Research
    • Studies
    • Support Cores
    • Working Groups and Task Forces
    • Resources for Researchers
    • The George R. Seage III Early Career Investigator Award
    • Research Network Partners
    • Collaborate with Us
    • Participate in the Study
    • Non-Disclosure Agreement (NDA)
  • Findings
    • Publications
    • PHACS in the News
    • Infographics Series
    • Research Summaries
    • Resúmenes de las Investigaciones
  • Community
    • COVID-19 and PHACS
    • Adult Community Advisory Board
    • Peers United Group (PUG)/YACAB
    • Health Education Resources
    • PHACS Film Series
    • Quarterly Digest
  • Contact Us
  • Register
  • Sign In
  • You are here:  
  • Home
  • / Findings
  • / Research Summaries
  • / HIV Complications

HIV Complications

In this category, you will find analyses about the long-term effects of HIV and anti-HIV medications. We focus on different parts of the body such as the kidneys, liver, and mouth, including teeth and gums. We are also interested in understanding the best way to manage anti-HIV medications as children with HIV grow up. Youth in our study have been exposed to many anti-HIV medications in their life, and they may experience challenges that may affect their ability to take medications.

 

Click to see an infographic of overall findings from the Complicatitons Working Group. 

Changes in Epigenetic Age Over Time in Youth with HIV and Youth Exposed to HIV

Studies in adults have shown that people with HIV may age faster than individuals without HIV. We wanted to know if this was true for young adults born with or exposed to HIV. One way to measure this faster aging is to look epigenetic aging and compare it to their actual age. 

Open PDF Summary Link to Publication

Higher Risk for Medical Problems as Youth Born with HIV Get Older

As youth living with HIV get older, they may have poor control of their HIV (higher viral loads and lower CD4 count). We wanted to know if teens and young adults born with HIV in the U.S. had more medical problems as they got older. Studying this can help us find ways to help them stay healthy.

Open PDF Summary Link to Publication

How Well the HPV Vaccine Works in Young Women Born with HIV

Women living with HIV may have a high risk of getting cervical cancers associated with the Human papillomavirus (HPV). Some vaccines such as the measles vaccine don’t seem to work as well in people living with HIV. We wanted to understand if there are ways to make the vaccine work better.

Open PDF Summary Link to Publication

Antiretroviral Drug Resistance Among Children with Perinatal HIV

In this study, we looked at how often children born with HIV have virus that is resistant to certain antiretroviral medications. We also looked for risk factors and warning signs that someone might be more likely to develop resistant virus. 

Open PDF Summary Link to Publication

Blood Test Abnormalities and Liver Disease Over Time in Teens and Young Adults Living with HIV

Liver disease in people with HIV can be due to many factors, including the HIV virus. Typically, we find liver disease by removing a small piece of the liver and examining it. This process is called a liver biopsy, and it can be uncomfortable and can lead to other problems, such as bleeding and infection. Some blood tests in adults have been used to tell if they may have liver disease without needing to have a liver biopsy. We wanted to study how useful these blood tests might be in teens and young adults living with HIV.

Open PDF Summary Link to Publication

Outcomes of Changes in Treatment After Treatment Failure in Youth Living with HIV

Most children with HIV are treated with combination antiretroviral therapy (cART). cART treatment failure can happen when the HIV medications are not controlling the virus well enough. We wanted to see how children who failed treatment were taken care of and how they responded to treatment.

Open PDF Summary Link to Publication

Chickenpox Vaccine and Babies Born with HIV

Some children with HIV may not make enough antibodies after they are vaccinated against chickenpox. In this study, we looked at factors that help children with HIV make long-lasting antibodies so that they stay protected against chickenpox. 

Open PDF Summary Link to Publication

HIV Drug Resistance in Youth Living with HIV

Some youth born with HIV may have tried many different HIV drugs during their lives and have few options left for treatment. In this study, we looked at the number of youth with a type of HIV that is resistant to a new medication that has been developed. 

Open PDF Summary

Energy Production and Babies Born to Mothers Living with HIV

Mitochondria are sometimes called the “batteries of the cells.” The drugs used to treat HIV can affect the way the mitochondria make energy. Fatty acid oxidation (FAO) is the process the body uses to turn fat into energy in the mitochondria. We wanted to see if HIV drugs affect FAO in uninfected babies born to mothers living with HIV.

Open PDF Summary Link to Publication

Immunity to Measles, Mumps, and Rubella in Youth with HIV

In this study, we looked at infected and uninfected youth born to mothers with HIV.  We looked at blood samples to see whether youth with HIV who had the Measles, Mumps, and Rubella (MMR) vaccine when they were babies, before they started antiretroviral therapy (ART), were still protected against MMR.

Please note that this abstract was presented at the 4th International Workshop On HIV Pediatrics in Washington, DC on July 20-21, 2012.

 

Open PDF Summary Link to Publication

Changes in ART in Youth with HIV

In this study, we looked at infected youth born to mothers with HIV and their patterns of HIV treatment over time. We studied how these medications affected the severity of their HIV illness.

Open PDF Summary Link to Publication

Stopping ART in Youth with HIV

In this study, we looked at infected youth born to mothers with HIV who stopped taking their HIV medicines to measure the status of  their HIV illness.  We described the characteristics of youth that stopped taking their medicines yet seemed to remain well.

Please note that this abstract was presented at the 16th Conference on Retroviruses and Opportunisitic Infections in Montreal, Canada on February 8-11, 2009.

Open PDF Summary

Retention of Participants in PHACS

In this study, we looked at youth in PHACS to see how many left the study early. We looked at the age and reasons that youth left the study to help us understand why they left.

Please note that this abstract was presented at the 16th International Workshop on HIV Observational Databases in Athens, Greece on March 29-31.

2012

 

Open PDF Summary

Youth with HIV and Insulin Resistance

In this study, we measured the amount of blood sugar and insulin (a hormone) in infected youth born to mothers with HIV. We divided youth into two groups based on how much insulin their bodies made to see if there were differences between the groupsand to see whether having HIV affects how the body makes insulin.

Open PDF Summary Link to Publication
Findings
Publications
PHACS in the News
Infographics Series
Research Summaries
Adolescent and Young Adult Health and Behaviors
Brain Development and Mental Health
Hearing and Language
Heart and Lung Health
HIV Complications
Maternal Exposures
Nutrition, Growth, and Metabolism
Women's Health
Resúmenes de las Investigaciones

Confidentiality Policy   |   Terms of Use   |   Powered by SiteRocket Labs

National Institutes of Health

Introducing the PHACS Member Area (BETA)